Member Info for Holdlong

Ross Millican and Alex Barriball have left bidstack. That’s the Director of Partnerships shown the door

Never had much time this week to do anything so have gone back and done my notes on the presentation in a quiet stress free moment this morning, picked up a few things I missed to be honest, here are my notes for those that want to save time. Beware they are the points I felt important there was a lot of pointless questions and repetition as far as I was concerned but it only means many new investors are joining so I should be tolerant.
Going forward I expect ORPH to be in a 'very, very different place in the next 2 weeks' to quote CF. I expect the characterisation study to complete next week with a lot of publicity and then 1, probably 2, CV19 challenge studies for £10million + to be announced. One alone will put us practically on last years revenues already and should cause a bit of rise. Regards POLB float I think we will be pleasantly surprised at the initial share rise there :0)
Notes on presentation
CF unable to buy shares as good news later this week or next week.
New £¼ trillion market in infectious diseases in 4 years, previously £10 billion ORPH at forefront
2 x £10 million challenge studies deals ‘in motion’
DiM is now patented and will be spun off, strongly hinted will be IPO
CF convinced we can create $1 billion value between ORPH and spin off in coming months and year, not years note.
Hinting at probably cash divi for Xmas
We will rewarded in coming weeks
Next couple of years vaccines will be needed for CV19
2 screening centres one London one Manchester
70 quarantine beds between 3 locations QMB, Whitechapel clinic (old hotel) and Royal Free Hospital, which is the largest number any company has world wide by a ’million miles’
DiM largest infectious disease progression database in the world
‘Data is the future’
POLB road show starts next week
POLB going to NASDAQ
Immune Modulator good for long covid
POLB have licensed limited access to ORPH database and biobank
PrEPBiopharm prophylactic with expected utility against CV19, cracking the whip to get it listed as separate company
By autumn all spin offs done.
Were operationally profitable Q4 2020
Cash balance £19 million up from £1 million at beginning year.
Money being spent on divi in species set up, data platform and challenge models
Cash balances will be strongly up on end of last year at end of this
2019 numbers had Venn and Open Orphan but 2020 has Hvivo as well
Costs have gone down by £3.5 million
Salary raises are not due to increase in salaries but to do with having an extra company, Hvivo since then 50 less heads at Hvivo
Revenue step up Q4 made ORPH profitable trend line continuing into 2021
£4 million challenge/lab contract wins 2019, £27 million 2020, 2021 YTD £15 million
Material win to be announced very, very soon which will bring us upto very close to 2020 total
4 to 6 month lead time from contract win to starting challenge study
New challenge study models including malaria, strep, pneumococcus, asthma etc contracts forming alre

Will look even cheaper at 2p. Last placing was done at a 29% discount to the share price on the day. Last year was the same everyone was surprised at no placing and then sure as night follows day it came along with a huge discount. It will happen, it won’t be good. It should provide those canny enough to get a lot of shares and not be diluted… Hope to see JD and FPS options diluted heavily

Has been from 2015... that was the point

You may think building out a sales team is positive but if all they are doing is reselling ads space into NHL20 and reselling static ads on fifa shirts for low margins.

I see that as panicking to get the revenue figure up at all costs to mask lack of progress.

I see new advisors coming on board as a reactionary to the current process not working.

I see the pivot to mobile games as a reaction to lack of traction in console and AAA games.

That is very different from the frictionless scalability of programmatic ads in household name Games that has been sold.

Interesting post on bidlievers

I was looking through the annual report a few months back, Fran claimed £120k worth of expenses in 2019, on top of his £135k salary.
Dropped to £15k in 2020, but the pandemic may have curbed his lavish spending.
Bidstack is just a lifestyle company for the founders.

Explained by tax credits and the reduction of silly expenses. A fundraise will happen in the next month, no surprise it’s not happened yet, the last one wasn’t easy by the sounds of it, it’s unusual to have to drop the price by 30% to get a placing away.

I think it will be more likely at 2.8p. The last raise was a 29% discount. The future outlook was better then.

- Better margins on the 9m forecast revenue. Meaning profitability could be hit at revenues of <20m now its <40m
- Nautilis hadn’t been taken over by Jetsynthesis and removed from Bidstacks platform
- miniclip hadn’t chosen anzu over bidstack
- EA hadn’t taken over Codemasters putting those games at risk. No way EA are agreeing to an exclusive contract with these fill rates

Based on what? There’s little to no evidence of ads being served. I think these results will hugely disappoint..... but they are second half waited arnt they

Yep will be lucky to raise above 3p. More competition arriving each day, with more visible progress from bidstack on signing AAA games.

These games are not exclusive to bidstack, And we’ve seen other providers like anzu and sayollo serving Google ads into these mobile games. Also Space invaders agency are showing their own ads in watch dogs so seems a free for all. Bids have lost the first leader advantage. https://www.linkedin.com/posts/the-space-invaders_onze-nieuwsbrief-is-er-weer-uit-met-deze-activity-6802489053565591552-Mxby

Who gives a crap about a couple of months they are at least 2-3 years from making a profit now guidance has been halved

Last placing was done at 29% discount to the closing sp. If that happens again we’re looking at 2.8p. Now tell me that’s not a complete failure of management.

Did you find the broker note?

Also marketscreener and investopedia etc all have it wrong.

2021 - 4m
https://m.marketscreener.com/quote/stock/BIDSTACK-GROUP-PLC-57419898/

Oh my... You can see the change here, second table down.

https://research-centre.barclays.co.uk/shares/bidstack-group/broker-views/broker-forecast/

6 months ago 9.05m
1 week ago 4m

If the note were true how would it change your investment decision monkey? Just asking as I believe this to be price sensitive information that hasn’t been forthcoming from the company and hidden from most PIs until funding is out of the way.

Has anyone asked the nomad, chairman or company on why the market hasn?t been informed that the revenue estimates that people invested for has suddenly halved halfway through the year...

Anyone know what happened to Real Cricket? Seen it’s been removed from bidstacks seller.json

Is this sad bastard helx still here.

Easily solved. Go to filters tab, enter ‘helx’, click filter chat. Save yourself a few mins a day.

In bidstack chat, it was good to see brands like Deliveroo and Netflix added to the client list.